Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,141 | 133 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ShockWave Medical, Inc | $1,380 | 13 | $0 (2024) |
| Medtronic, Inc. | $1,161 | 17 | $0 (2023) |
| Boston Scientific Corporation | $1,129 | 14 | $0 (2024) |
| Cardiovascular Systems Inc. | $411.62 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $402.01 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $341.33 | 11 | $0 (2024) |
| Abbott Laboratories | $335.09 | 5 | $0 (2024) |
| ABIOMED | $272.80 | 2 | $0 (2024) |
| Novo Nordisk Inc | $210.87 | 3 | $0 (2022) |
| Philips Electronics North America Corporation | $210.06 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,536 | 26 | Boston Scientific Corporation ($465.88) |
| 2023 | $1,698 | 35 | ShockWave Medical, Inc ($651.35) |
| 2022 | $1,495 | 24 | Shockwave Medical, Inc ($409.12) |
| 2021 | $2,412 | 48 | Medtronic, Inc. ($644.44) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 3 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/02/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: DIABETES | ||||||
| 02/15/2023 | Philips Electronics North America Corporation | (6575) Coronary Undivided (Device) | Food and Beverage | Cash or cash equivalent | $83.87 | General |
| Category: Medical Device | ||||||
| 02/14/2023 | Philips Electronics North America Corporation | (6575) Coronary Undivided (Device) | Food and Beverage | Cash or cash equivalent | $107.14 | General |
| Category: Medical Device | ||||||
| 02/06/2023 | Philips Electronics North America Corporation | (6571) Eagle Eye (Device) | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: Medical Device | ||||||
| 02/02/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/25/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/20/2023 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: AVVIGO_IC | ||||||
| 01/18/2023 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $49.97 | General |
| Category: AVVIGO_IC | ||||||
| 01/05/2023 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $115.50 | General |
| Category: AVVIGO_IC | ||||||
| 12/15/2022 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $151.82 | General |
| Category: Stents | ||||||
| 12/15/2022 | Shockwave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $103.43 | General |
| Category: Lithoplasty | ||||||
| 12/05/2022 | Shockwave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Lithoplasty | ||||||
| 12/01/2022 | Cardiovascular Systems Inc. | Diamondback Coronary (Device) | Food and Beverage | Cash or cash equivalent | $146.23 | General |
| Category: Atherectomy Device | ||||||
| 11/28/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Genetic Disease | ||||||
| 11/23/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/03/2022 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $161.61 | General |
| Category: AVVIGO_IC | ||||||
| 10/15/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $109.62 | General |
| Category: Diabetes | ||||||
| 10/14/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: DIABETES | ||||||
| 07/29/2022 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Stents | ||||||
| 07/22/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Cardiovascular | ||||||
| 07/15/2022 | Shockwave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $45.21 | General |
| Category: Lithoplasty | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 161 | 175 | $23,195 | $8,601 |
| 2022 | 8 | 206 | 234 | $33,520 | $11,947 |
| 2021 | 5 | 76 | 85 | $13,405 | $4,927 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 41 | $6,970 | $2,962 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 27 | 35 | $6,125 | $1,930 | 31.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 24 | 24 | $4,200 | $1,612 | 38.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 13 | 13 | $2,600 | $716.54 | 27.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 14 | $1,260 | $645.40 | 51.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 24 | 24 | $1,200 | $441.36 | 36.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 24 | 24 | $840.00 | $294.00 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 43 | 65 | $11,375 | $4,008 | 35.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 34 | 34 | $6,800 | $2,119 | 31.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 28 | 28 | $4,900 | $1,893 | 38.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 19 | $3,230 | $1,257 | 38.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,750 | $1,054 | 38.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 16 | 21 | $2,100 | $731.30 | 34.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 27 | 27 | $1,350 | $510.44 | 37.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 29 | 29 | $1,015 | $373.24 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 26 | $4,550 | $1,607 | 35.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 23 | $3,910 | $1,554 | 39.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 13 | 13 | $2,600 | $833.95 | 32.1% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2021 | 11 | 11 | $1,925 | $772.09 | 40.1% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 12 | 12 | $420.00 | $159.24 | 37.9% |
About Astha Tejpal
Astha Tejpal is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1558778506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Astha Tejpal has received a total of $7,141 in payments from pharmaceutical and medical device companies, with $1,536 received in 2024. These payments were reported across 133 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($7,141).
As a Medicare-enrolled provider, Tejpal has provided services to 443 Medicare beneficiaries, totaling 494 services with total Medicare billing of $25,475. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Internal Medicine
- Location Brooklyn, NY
- Active Since 07/22/2014
- Last Updated 09/24/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1558778506
Products in Payments
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $1,060
- Resolute (Device) $612.44
- AVVIGO Guidance System (Device) $505.70
- ONYX FRONTIER (Device) $436.18
- ENTRESTO (Drug) $402.01
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $319.70
- Impella (Device) $272.80
- Diamondback Peripheral (Device) $265.39
- ROTAPRO (Device) $203.95
- (6575) Coronary Undivided (Device) $191.01
- Repatha (Biological) $185.43
- JARDIANCE (Drug) $180.72
- Indigo System (Device) $180.23
- FARXIGA (Drug) $172.42
- RESONATE EL ICD VR (Device) $160.79
- LifeVest (Device) $154.79
- Diamondback Coronary (Device) $146.23
- ULTREON (Device) $140.00
- XARELTO (Drug) $138.65
- Confirm Rx (Device) $118.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799